nm23 is expressed in reactive mesothelium and is not useful for detection of malignant cells in serous effusions

Oncology Reports

Volumn 15, Issue 1, 2006, Pages 85-88

  Zimmerman, Robert L ^a   Fogt, Franz ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cytology; Effusions; Malignant effusions; Mesothelium; nm23

Indexed keywords

NUCLEOSIDE DIPHOSPHATE KINASE; NUCLEOSIDE DIPHOSPHATE KINASE A; TUMOR MARKER;

ADENOCARCINOMA; ARTICLE; BODY FLUID; CARCINOMA; ENZYMOLOGY; EPITHELIUM; HUMAN; IMMUNOHISTOCHEMISTRY; MESOTHELIOMA; METABOLISM; PATHOLOGY; SEROSA;

ADENOCARCINOMA; BODY FLUIDS; CARCINOMA; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; MESOTHELIOMA; NUCLEOSIDE-DIPHOSPHATE KINASE; SEROUS MEMBRANE; TUMOR MARKERS, BIOLOGICAL;

EID: 33644876396     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.1.85     Document Type: Article

References (19)

1. Queiroz C, Barral-Netto M and Bacchi CE: Characterizing subpopulations of neoplastic cells in serous effusions: The role of immunocytochemistry. Acta Cytol 45: 18-22, 2001. (Pubitemid 32117710)
2. Osborn M and Wenancjusz D: Special techniques in cytopathology. In: Comprehensive Cytopathology, Marluce Bibbo, 2nd ed. WB Saunders, Philadelphia, pp1058-1060, 1996.
3. Fetch PA and Abati A: Immunocytochemistry in effusion cytology: a contemporary review. Cancer Cytopathol 93: 293-308, 2001.
4. Ferrandez-Izquierdo A, Navarro-Fos S, Gonzalez-Devesa M, Gil-Benso R and Llombar-Bosch A: Immunocytochemical typification of mesothelial cells in effusions: in vivo and in vitro models. Diagn Cytopathol 10: 256-262, 1994. (Pubitemid 24139827)
5. Saha I, Dey P, Vhora H and Nijhawan R: Role of DNA flow cytometry and image cytometry on effusion fluid. Diagn Cytopathol 22: 81-85, 2000. (Pubitemid 30069048)
6. Dejmek A, Yahata N, Ohyashiki K, Ebihara Y, Kakihane M, Hirano T, Kawate N and Kato H: In situ telomerase activity in pleural effusions: a promising marker for malignancy. Diagn Cytopathol 24: 11-15, 2001. (Pubitemid 32039039)
7. Cappellari A, Furlan C, Cardellini P, Bagarella M and Corradi G: Morphologic analysis of effusion cells by scanning electron microscopy. Tumori 78: 10-12, 1992.
8. Graham AJN, Maxwell P, Mulholland K, Patterson AH, Anderson N, McManus KG, Bharucha H and McGuigan JA: Increased nm23 immunoreactivity is associated with selective inhibition of systemic tumour cell dissemination. J Clin Pathol 55: 184-190, 2002. (Pubitemid 34250903)
9. Takes RP, Baatenburg de Jong RJ, Wijffels K, Schuuring E, Litinov SV, Hemans J and van Krieken JHJM: Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer. J Pathol 194: 198-302, 2001.
10. Ouatas T, Salerno M, Palmieri D and Steeg PS: Basic and translational advances in cancer metastasis: Nm23. J Bioenerg Biomembr 35: 73-79, 2003. (Pubitemid 36667583)
11. Cipollini G, Beryi A, Fiore L, Rainaldi G, Basolo F, Merlo G, Belivacqua G and Caligo MA: Down-regulation of the nm23.h1 gene inhibits cell proliferation. Int J Cancer 73: 297-302, 1997. (Pubitemid 27448834)
12. Gunther K, Dworak O, Remke S, Pfluger R, Merkel S, Hohenberger W and Termond MA: Prediction of distant metastases after curative surgery for rectal cancer. J Surg Res 103: 68-78, 2002. (Pubitemid 34953394)
13. Gunchert VN, del-Rosario A, Kren L, Anwar S, Sheehan CE, Carlson JA and Ross JS: Co-downregulation of PTEN, KAI-1 and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer. Ann Diagn Pathol 8: 6-16, 2004. (Pubitemid 38199173)
14. Simone G, Galco G, Caponio MA, Campobasso C, De Frenza M, Petroni S, Wiesel S and Leone A: nm23 expression in malignant ascitic effusions of serous ovarian adenocarcinoma. Int J Oncol 19: 885-990, 2001.
15. Harlozinska A, Bar JK and Gerber J: nm23 expression in tissue sections and tumor effusion cells of ovarian neoplasms. Int J Cancer 69: 415-419, 1996. (Pubitemid 26384113)
16. Zimmerman RL and Fogt F: The β subunit of human chorionic gonadotropin lacks specificity for malignant cells in serous effusions. Mod Pathol 17: 701-704, 2004. (Pubitemid 38715494)
17. Zimmerman RL and Fogt F: Evaluation of the c-Met immunostain to detect malignant cells in body cavity effusions. Oncol Rep 8: 1347-1350, 2001. (Pubitemid 33758744)
18. Zimmerman RL, Goonewardene S and Fogt F: Glucose transporter Glut-1 is of limited value for detecting breast carcinoma in serous effusions. Mod Pathol 14: 748-751, 2001. (Pubitemid 33069832)
19. Zimmerman RL, Fogt F and Goonewardene S: Diagnostic value of a second generation CA 15-3 antibody to detect adenocarcinoma in body cavity effusions. Cancer Cytopathol 90: 230-234, 2000. (Pubitemid 30660110)